Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PH vs GSK✓SelectedUSD · GSKPH vs GSK performance historyLatest closeAs of-2.18%11/16
Stock and ETF performance explorer

PH vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+125.6%
GSK return
+64.4%
Excess return
+61.2%
Maximum drawdown
-26.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.2%-0.1%-2.1%-2.2%
7D-2.1%-1.3%-0.8%-1.9%
30D-2.8%+2.7%-5.5%-3.2%
3M-11.1%+2.7%-13.8%-11.6%
6M+8.8%+3.3%+5.5%+8.0%
YTD+7.2%+6.5%+0.8%+6.4%
1Y+13.3%+10.7%+2.6%+11.9%
3Y+125.6%+64.4%+61.3%+105.3%
All+125.6%+64.4%+61.2%+105.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling